Prof. Muhammad Raza Shah is a professor and Director of the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. He holds four US patents. Dr. Shah has received numerous awards, including the Khwarizmi International Award from the Ministry of Science, Research and Technology, Iran (2023). He has also been honored with the Civil Award Tamgha-i-Imtiaz (2015), Dr. Raziuddin Prize (2015), Prof. Atta-ur-Rahman Gold Medal by the Pakistan Academy of Sciences, Avicenna Science & Innovation Award (2015) by Brain Trust UK, and the Abdus Salam Award in Chemistry (2006). He was named TWAS Young Affiliate in 2010 by The World Academy of Sciences. Prof. Shah is a Fellow of the International Union of Pure and Applied Chemistry, the Chemical Society of Pakistan, the Islamic World Academy of Sciences, and the Royal College of Physicians (Edinburgh). Dr. Shah has conducted 29 Phase-I (BE and PK) studies, 04 Phase-II Randomized Clinical Trial as PI and lead the Phase-I RCT of Sinopharm COVID-19 vaccine and Phase-III RCT of COVID-19 booster vaccine as country PI. Dr. Tooba Jabri completed her PhD in organic chemistry (2023) at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. She has been a recipient of a national-level scholarship from the Higher Education Commission (HEC) of Pakistan, and has conducted research as part of the HORIZON 2020 INFUSION project at Cardiff University, United Kingdom. Her focus areas include design and development of nanomaterials, drug delivery system, and synthesis of organic and polymeric materials. Dr. Maria Khalid earned her MSc in Chemistry (2008) from Quaid e Azam University, graduating at the top of her class and receiving the Chancellor’s Medal for academic excellence, along with a national-level scholarship from the Higher Education Commission (HEC) of Pakistan. Dr. Khalid completed her PhD in 2025 at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan, focusing on the design and development of innovative polymer-based materials for biomedical and therapeutic applications.

• 1. Introduction2. Endogenous and Exogenous Stimuli-Responsive Nanoscale Drug Delivery Systems3. pH Responsive Nanocarriers for Drug Delivery4. Temperature Responsive Nanocarriers for Drug Delivery5. Light Responsive Nanocarriers for Drug Delivery6. Redox Responsive Nanocarriers for Drug Delivery7. Enzyme Responsive Nanocarriers for Drug Delivery8. Ultrasound Responsive Nanocarriers for Drug Delivery9. Magnetic Field Responsive Nanocarriers for Drug Delivery10. Electrical Responsive Nanocarriers for Drug Delivery11. Dual and Multiple Responsive Nanocarriers for Drug Delivery12. Stimuli-Responsive Nanocarriers in Clinical Translation

Prof. Muhammad Raza Shah is a professor and Director of the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. He holds four US patents. Dr. Shah has received numerous awards, including the Khwarizmi International Award from the Ministry of Science, Research and Technology, Iran (2023). He has also been honored with the Civil Award Tamgha-i-Imtiaz (2015), Dr. Raziuddin Prize (2015), Prof. Atta-ur-Rahman Gold Medal by the Pakistan Academy of Sciences, Avicenna Science & Innovation Award (2015) by Brain Trust UK, and the Abdus Salam Award in Chemistry (2006). He was named TWAS Young Affiliate in 2010 by The World Academy of Sciences. Prof. Shah is a Fellow of the International Union of Pure and Applied Chemistry, the Chemical Society of Pakistan, the Islamic World Academy of Sciences, and the Royal College of Physicians (Edinburgh). Dr. Shah has conducted 29 Phase-I (BE and PK) studies, 04 Phase-II Randomized Clinical Trial as PI and lead the Phase-I RCT of Sinopharm COVID-19 vaccine and Phase-III RCT of COVID-19 booster vaccine as country PI. Dr. Tooba Jabri completed her PhD in organic chemistry (2023) at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. She has been a recipient of a national-level scholarship from the Higher Education Commission (HEC) of Pakistan, and has conducted research as part of the HORIZON 2020 INFUSION project at Cardiff University, United Kingdom. Her focus areas include design and development of nanomaterials, drug delivery system, and synthesis of organic and polymeric materials. Dr. Maria Khalid earned her MSc in Chemistry (2008) from Quaid e Azam University, graduating at the top of her class and receiving the Chancellor’s Medal for academic excellence, along with a national-level scholarship from the Higher Education Commission (HEC) of Pakistan. Dr. Khalid completed her PhD in 2025 at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan, focusing on the design and development of innovative polymer-based materials for biomedical and therapeutic applications.

• 1. Introduction2. Endogenous and Exogenous Stimuli-Responsive Nanoscale Drug Delivery Systems3. pH Responsive Nanocarriers for Drug Delivery4. Temperature Responsive Nanocarriers for Drug Delivery5. Light Responsive Nanocarriers for Drug Delivery6. Redox Responsive Nanocarriers for Drug Delivery7. Enzyme Responsive Nanocarriers for Drug Delivery8. Ultrasound Responsive Nanocarriers for Drug Delivery9. Magnetic Field Responsive Nanocarriers for Drug Delivery10. Electrical Responsive Nanocarriers for Drug Delivery11. Dual and Multiple Responsive Nanocarriers for Drug Delivery12. Stimuli-Responsive Nanocarriers in Clinical Translation

Prof. Muhammad Raza Shah is a professor and Director of the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. He holds four US patents. Dr. Shah has received numerous awards, including the Khwarizmi International Award from the Ministry of Science, Research and Technology, Iran (2023). He has also been honored with the Civil Award Tamgha-i-Imtiaz (2015), Dr. Raziuddin Prize (2015), Prof. Atta-ur-Rahman Gold Medal by the Pakistan Academy of Sciences, Avicenna Science & Innovation Award (2015) by Brain Trust UK, and the Abdus Salam Award in Chemistry (2006). He was named TWAS Young Affiliate in 2010 by The World Academy of Sciences. Prof. Shah is a Fellow of the International Union of Pure and Applied Chemistry, the Chemical Society of Pakistan, the Islamic World Academy of Sciences, and the Royal College of Physicians (Edinburgh). Dr. Shah has conducted 29 Phase-I (BE and PK) studies, 04 Phase-II Randomized Clinical Trial as PI and lead the Phase-I RCT of Sinopharm COVID-19 vaccine and Phase-III RCT of COVID-19 booster vaccine as country PI. Dr. Tooba Jabri completed her PhD in organic chemistry (2023) at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan. She has been a recipient of a national-level scholarship from the Higher Education Commission (HEC) of Pakistan, and has conducted research as part of the HORIZON 2020 INFUSION project at Cardiff University, United Kingdom. Her focus areas include design and development of nanomaterials, drug delivery system, and synthesis of organic and polymeric materials. Dr. Maria Khalid earned her MSc in Chemistry (2008) from Quaid e Azam University, graduating at the top of her class and receiving the Chancellor’s Medal for academic excellence, along with a national-level scholarship from the Higher Education Commission (HEC) of Pakistan. Dr. Khalid completed her PhD in 2025 at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan, focusing on the design and development of innovative polymer-based materials for biomedical and therapeutic applications.

• 1. Introduction2. Endogenous and Exogenous Stimuli-Responsive Nanoscale Drug Delivery Systems3. pH Responsive Nanocarriers for Drug Delivery4. Temperature Responsive Nanocarriers for Drug Delivery5. Light Responsive Nanocarriers for Drug Delivery6. Redox Responsive Nanocarriers for Drug Delivery7. Enzyme Responsive Nanocarriers for Drug Delivery8. Ultrasound Responsive Nanocarriers for Drug Delivery9. Magnetic Field Responsive Nanocarriers for Drug Delivery10. Electrical Responsive Nanocarriers for Drug Delivery11. Dual and Multiple Responsive Nanocarriers for Drug Delivery12. Stimuli-Responsive Nanocarriers in Clinical Translation